目的分析实施强化口腔护理对于慢性牙周炎种植治疗患者口腔保健行为与口腔功能恢复的促进价值。方法随机选取2021年1月—2022年12月期间济南市口腔医院实施口腔种植治疗的80例慢性牙周炎患者为研究对象,依据不同护理方法分为对照组和观...目的分析实施强化口腔护理对于慢性牙周炎种植治疗患者口腔保健行为与口腔功能恢复的促进价值。方法随机选取2021年1月—2022年12月期间济南市口腔医院实施口腔种植治疗的80例慢性牙周炎患者为研究对象,依据不同护理方法分为对照组和观察组,各40例。对照组患者实施常规护理干预,观察组患者实施强化口腔护理,比较两组患者的口腔保健自我效能量表(Self-efficacy Scale for Oral Health,SEES)评分、生活质量评分以及护理满意度。结果护理后,观察组刷牙次数、刷牙时间、间隙清洁以及SEES总分均优于对照组,差异有统计学意义(P均<0.05);护理后,观察组生活质量评分高于对照组,差异有统计学意义(P<0.05);观察组护理满意度为95.00%(38/40),高于对照组的80.00%(32/40),差异有统计学意义(χ^(2)=4.114,P=0.043)。结论慢性牙周炎种植治疗患者实施强化口腔护理可提升患者的口腔自我保健行为的自我效能,促进患者的口腔保健行为实施,以促进患者的牙周健康恢复,具有重要应用价值。展开更多
The market for active implants and biosensors is of high economic and medical interest. As health economic considerations get into focus in terms of business planning and reimbursement, valid and flexible economic fea...The market for active implants and biosensors is of high economic and medical interest. As health economic considerations get into focus in terms of business planning and reimbursement, valid and flexible economic feasibility studies get more important. Unfortunately, literature mostly provides only single economic views on specific aspects like cost savings from reduced rehabilitation in a special patient cohort. To make planning and technology value negotiation more effective and more valid, a methodology to collect relevant data from different studies and normalize it to a common set of parameters was developed for the field of cardiac monitoring in a mixed example population with an approach of simple external weight, ECG and blood-pressure measurement or implanted devices for cardiac monitoring. The target entities taken into account by the simulation model were the impacts on heart attack, stroke, heart failure and the process of implant monitoring. Simulation took place at an example population of 500 patients with specific morbidity criteria. The health economic value was calculated over a period of three years and was split into a technology effectiveness measurement in Quality-adjusted-Lifetime-Years (QALYs) and a “cost- saving-part”. QALYs were chosen as technology effectiveness parameter for a combined and weighted mortality- and morbidity-reduction. Allocating 24.000 Euro to a saved QALY, 42% of the cost would be allocated to QALYs meaning money being spent for gained lifetime-years. The remaining 58% would be the different real cost savings: a per patient gross saving of 3.308 € per year would result for that part (21% on heart attack, 3% on stroke, 68% on heart failure and 8% on implant monitoring). Up-to-date studies do not provide a simple mechanism to allow custom-tailored health economic feasibility study results in terms of other specific population mixes or outcome parameters. Target audiences for the methodology of the described simulation are payors and solution providers targeting a specific patient population or specific telemedical situations. This way product development can address market-related needs more specific and healthcare providers can compare different outcome parameters in the given entities.展开更多
文摘目的分析实施强化口腔护理对于慢性牙周炎种植治疗患者口腔保健行为与口腔功能恢复的促进价值。方法随机选取2021年1月—2022年12月期间济南市口腔医院实施口腔种植治疗的80例慢性牙周炎患者为研究对象,依据不同护理方法分为对照组和观察组,各40例。对照组患者实施常规护理干预,观察组患者实施强化口腔护理,比较两组患者的口腔保健自我效能量表(Self-efficacy Scale for Oral Health,SEES)评分、生活质量评分以及护理满意度。结果护理后,观察组刷牙次数、刷牙时间、间隙清洁以及SEES总分均优于对照组,差异有统计学意义(P均<0.05);护理后,观察组生活质量评分高于对照组,差异有统计学意义(P<0.05);观察组护理满意度为95.00%(38/40),高于对照组的80.00%(32/40),差异有统计学意义(χ^(2)=4.114,P=0.043)。结论慢性牙周炎种植治疗患者实施强化口腔护理可提升患者的口腔自我保健行为的自我效能,促进患者的口腔保健行为实施,以促进患者的牙周健康恢复,具有重要应用价值。
文摘The market for active implants and biosensors is of high economic and medical interest. As health economic considerations get into focus in terms of business planning and reimbursement, valid and flexible economic feasibility studies get more important. Unfortunately, literature mostly provides only single economic views on specific aspects like cost savings from reduced rehabilitation in a special patient cohort. To make planning and technology value negotiation more effective and more valid, a methodology to collect relevant data from different studies and normalize it to a common set of parameters was developed for the field of cardiac monitoring in a mixed example population with an approach of simple external weight, ECG and blood-pressure measurement or implanted devices for cardiac monitoring. The target entities taken into account by the simulation model were the impacts on heart attack, stroke, heart failure and the process of implant monitoring. Simulation took place at an example population of 500 patients with specific morbidity criteria. The health economic value was calculated over a period of three years and was split into a technology effectiveness measurement in Quality-adjusted-Lifetime-Years (QALYs) and a “cost- saving-part”. QALYs were chosen as technology effectiveness parameter for a combined and weighted mortality- and morbidity-reduction. Allocating 24.000 Euro to a saved QALY, 42% of the cost would be allocated to QALYs meaning money being spent for gained lifetime-years. The remaining 58% would be the different real cost savings: a per patient gross saving of 3.308 € per year would result for that part (21% on heart attack, 3% on stroke, 68% on heart failure and 8% on implant monitoring). Up-to-date studies do not provide a simple mechanism to allow custom-tailored health economic feasibility study results in terms of other specific population mixes or outcome parameters. Target audiences for the methodology of the described simulation are payors and solution providers targeting a specific patient population or specific telemedical situations. This way product development can address market-related needs more specific and healthcare providers can compare different outcome parameters in the given entities.
